WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014181314) PLACENTAL LIKE ALKALINE PHOSPHATASE (PLAP) PROMOTER MEDIATED CELL TARGETING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/181314    International Application No.:    PCT/IB2014/061350
Publication Date: 13.11.2014 International Filing Date: 10.05.2014
IPC:
A61K 48/00 (2006.01), C12N 15/63 (2006.01)
Applicants: DEPARTMENT OF BIOTECHNOLOGY [IN/IN]; Block-2, 7th Floor, C.G.O. Complex Lodi Road New Delhi 110 003 (IN).
NATIONAL BRAIN RESEARCH CENTRE [IN/IN]; NH-8, Near NSG Campus Nainwal Mode Manesar 122 051 Haryana (IN).
ALL INDIA INSTITUTE OF MEDICAL SCIENCES [IN/IN]; Ansari Nagar 29 Aurobindo Marg New Delhi 110 029 (IN)
Inventors: SINHA, Subrata; (IN).
KHAN, Imran; (IN).
ZAKARIA, Mohammad Khalid; (IN).
CHOSDOL, Kunzang; (IN).
CHATTOPADHYAY, Parthaprasad; (IN)
Agent: NAIR, Manisha Singh; Lex Orbis Intellectual Property Practice 709/710, Tolstoy House 15 - 17, Tolstoy Marg New Delhi 110 001 (IN)
Priority Data:
1400/DEL/2013 10.05.2013 IN
Title (EN) PLACENTAL LIKE ALKALINE PHOSPHATASE (PLAP) PROMOTER MEDIATED CELL TARGETING
(FR) CIBLAGE CELLULAIRE MÉDIÉ PAR UN PROMOTEUR DE PHOSPHATASE ALCALINE D'ORIGINE PLACENTAIRE (PLAP)
Abstract: front page image
(EN)The present invention relates to cell specific therapeutic modality by using a region of the PLAP Promoter. The invention further relates to specific expression of therapeutically PLAP useful sequences for specific transcriptional activation of this gene. The invention also relates to the PLAP region which may be used alone or in combination with other regions like enhancer sequences that augment cell or tumour specific gene expression.
(FR)Cette invention concerne des modalités thérapeutiques spécifiques des cellules faisant appel à une région du promoteur PLAP. Cette invention concerne également l'expression spécifique de séquences thérapeutiquement utiles de PLAP pour l'activation transcriptionnelle spécifique de ce gène. La région PLAP peut être utilisée seule ou en combinaison avec d'autres régions comme des séquences activatrices qui augmentent l'expression génique spécifique des cellules ou des tumeurs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)